Interferon-γ inhibits group B Streptococcus survival within human endothelial cells

Mem Inst Oswaldo Cruz. 2014 Nov;109(7):940-3. doi: 10.1590/0074-0276140201. Epub 2014 Oct 28.

Abstract

Endothelial dysfunction is a major component of the pathophysiology of septicaemic group B Streptococcus (GBS) infections. Although cytokines have been shown to activate human umbilical vein endothelial cells (HUVECs), the capacity of interferon (IFN)-γ to enhance the microbicidal activity of HUVECs against GBS has not been studied. We report that the viability of intracellular bacteria was reduced in HUVECs activated by IFN-γ. Enhanced fusion of lysosomes with bacteria-containing vacuoles was observed by acid phosphatase and the colocalisation of Rab-5, Rab-7 and lysosomal-associated membrane protein-1 with GBS in IFN-γ-activated HUVECs. IFN-γ resulted in an enhancement of the phagosome maturation process in HUVECs, improving the capacity to control the intracellular survival of GBS.

MeSH terms

  • Acid Phosphatase / metabolism
  • Anti-Infective Agents / pharmacology*
  • Bacterial Adhesion / drug effects
  • Endocytosis
  • Human Umbilical Vein Endothelial Cells / metabolism
  • Human Umbilical Vein Endothelial Cells / microbiology*
  • Humans
  • Interferon-gamma / pharmacology*
  • Lysosomes / drug effects
  • Microbial Viability / drug effects*
  • Phagosomes / drug effects
  • Primary Cell Culture
  • Streptococcal Infections / drug therapy*
  • Streptococcal Infections / prevention & control
  • Streptococcus agalactiae / drug effects*
  • Survival Analysis

Substances

  • Anti-Infective Agents
  • Interferon-gamma
  • Acid Phosphatase